ORAGENICS, INC. (OGEN) Return on equity 2016–2024
ORAGENICS, INC. (OGEN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-333.6%FY2024 · since FY2016: -148.2% → -333.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -333.6% | -174.8 pp |
| FY2023 | -158.8% | -104.8 pp |
| FY2022 | -53.9% | — |
| FY2018 | -157.0% | +70.0 pp |
| FY2017 | -227.0% | -78.7 pp |
| FY2016 | -148.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More OGEN financial trends
OGEN RevenueOGEN Net incomeOGEN Net marginOGEN Gross profitOGEN Gross marginOGEN Operating incomeOGEN Operating marginOGEN Operating cash flowOGEN Free cash flowOGEN Capital expendituresOGEN Stock buybacksOGEN Dividends paidOGEN Total assetsOGEN Total liabilitiesOGEN Shareholders’ equityOGEN overview →